Skip to main content
. Author manuscript; available in PMC: 2015 Jan 1.
Published in final edited form as: Cancer Lett. 2013 Sep 2;342(1):104–112. doi: 10.1016/j.canlet.2013.08.040

Fig 2.

Fig 2

Transfection with synthetic CDK11 siRNA decreases cell proliferation in SW872 and SW982 cells. (A) Cell growth and proliferation of SW872 and SW982 was determined by transfection with either nonspecific siRNA or CDK11 siRNA at 40nmol/L concentration. (B) Representative images of liposarcoma cells after transfection of nonspecific siRNA or CDK11 siRNA in 96-well plate. (C) Western blotting confirmed that knockdown of CDK11 by transfection with 40nmol/L siRNA significantly decreased the CDK11protein expression.